Max Healthcare (MAXHEALTH) Stock Price, Fundamentals & Analysis
Price
1,014 INR
-3.06%
Last trade: Sep 25, 2026, 03:14 PM GMT+5:30
Updated: Sep 27, 2026, 03:15 PM GMT+5:30
Price history
Over the past year MAXHEALTH traded between 931.6 INR and 1,211 INR, closing at 1,014 INR on Sep 25, 2026.
Key statistics
| Market cap | 986.94B INR |
|---|---|
| P/E ratio (TTM) | 68 |
| Forward P/E | 43.4 |
| EPS (TTM) | 14.91 INR |
| Dividend yield | 0.2% |
| Annual dividend | 2 INR |
| Ex-dividend date | Jul 3, 2026 |
| Payout ratio | 13% |
| 52-week range | 903 – 1,221.9 |
| 52-week change | -5.9% |
| Beta | 0.11 |
| Price / book | 9.18 |
| Revenue (TTM) | 87.12B INR |
| Revenue growth (YoY) | 16.7% |
| Gross margin | 62.5% |
| Operating margin | 19.7% |
| Profit margin | 16.7% |
| Debt / equity | 32.4 |
| Volume | 1,900,517 |
| Average volume | 1,865,987 |
| Next earnings | Nov 20, 2026 |
| Exchange | NSE |
Profile
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Gurugram, India
- Website
- maxhealthcare.in
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, bone marrow transplant, bariatric/weight loss surgery, gynecology, minimal access/laparoscopic surgery, eye care/ophthalmology, robotic surgery, paediatrics, nephrology, liver and biliary sciences, gastroenterology and GI surgery, internal medicine, organ transplants, and plastic and reconstructive surgery. The company also provides Max@Home, a platform that offers health and wellness services at home; and Max Lab, which provides diagnostic testing services to patients. In addition, it offers organ and tissue donation, preventive health checks, ambulance and immigration, air ambulance, and insurance and TPA services. The company provides healthcare services through a network of primary care clinics, multi-specialty hospitals/medical centres, and super-specialty hospital facilities. Max Healthcare Institute Limited was incorporated in 2001 and is based in Gurugram, India.
Overview
What MAXHEALTH does
Max Healthcare (MAXHEALTH) is a stock listed on the National Stock Exchange of India that operates in the Healthcare sector, specifically the Medical Care Facilities industry. The company provides a wide range of medical services in India, including cardiac sciences, orthopedics, oncology, neurosciences, organ transplants, robotic surgery, and pediatric care. It also operates Max@Home for home-based health and wellness services, Max Lab for diagnostic testing, and offers support services such as ambulance, insurance, and organ donation. Through a network of primary care clinics, multi-specialty hospitals, and super-specialty facilities, Max Healthcare delivers both inpatient and outpatient care across the country.
Key numbers explained
- Price: The current share price is 1,014 INR, representing the cost to buy one unit of ownership in the company.
- Market cap: At 986.94B INR, this is the total market value of all outstanding shares, reflecting how the market sizes the company.
- Trailing P/E ratio: 68 means the share price is 68 times the last twelve months' earnings per share of 14.91 INR, a metric used to gauge how much investors are paying for each rupee of earnings.
- Forward P/E ratio: 43.4 uses expected future earnings, suggesting a lower valuation if those estimates hold.
- Dividend yield: 0.2% indicates the annual dividend relative to the share price, showing the cash return shareholders receive.
- Beta: 0.11 suggests the stock tends to be much less volatile than the broader market.
- Revenue growth: 16.7% year-over-year shows how quickly the company's top line has expanded.
- Debt-to-equity ratio: 32.4% measures financial leverage, comparing borrowed funds to shareholders' equity.
What to watch
Investors tracking Max Healthcare may consider factors common to healthcare providers, such as changes in patient volumes, regulatory developments in the Indian medical sector, and competition from peers like Dr. Reddy's Laboratories (DRREDDY), Cipla (CIPLA), and Apollo Hospitals (APOLLOHOSP). The company's mix of specialties, its diagnostic and home-care platforms, and its exposure to medical tourism and insurance dynamics can also influence performance. Broader economic conditions, interest rate environments, and currency movements affecting the Indian rupee are additional factors that may be relevant when considering any stock listed on the National Stock Exchange of India.
Latest news & filings
No recent headlines.
Frequently asked questions
Does MAXHEALTH pay a dividend?
Yes, Max Healthcare pays a dividend with a yield of 0.2%, and 13% of earnings are distributed to shareholders. The ex-dividend date is Jul 3, 2026.
What is the MAXHEALTH P/E ratio?
The trailing P/E ratio is 68, while the forward P/E ratio based on expected earnings is 43.4.
Where can I buy MAXHEALTH?
MAXHEALTH trades on the National Stock Exchange of India. You can buy it through any broker that provides access to Indian equities.
What sector is Max Healthcare in?
It operates in the Healthcare sector, specifically the Medical Care Facilities industry.
How has MAXHEALTH performed over the past year?
The stock price changed by -5.9% over the last 52 weeks, with a low of 903 INR and a high of 1,221.9 INR.
What is Max Healthcare's beta?
The beta is 0.11, indicating lower volatility compared to the overall market.
Related
More on MAXHEALTH
Track MAXHEALTH in your portfolio
Hold MAXHEALTH at XTB, IBKR, Tradeville, Revolut or Trading 212? InvestPane brings every broker into one dashboard — allocation, performance and dividends in one place.
Start free